BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25636427)

  • 1. Tissue Heterogeneity as a Pre-analytical Source of Variability.
    Stanta G
    Recent Results Cancer Res; 2015; 199():35-43. PubMed ID: 25636427
    [No Abstract]   [Full Text] [Related]  

  • 2. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
    Roux J; Gouzé JL; Hofman P
    Med Sci (Paris); 2015 Jan; 31(1):28-31. PubMed ID: 25658727
    [No Abstract]   [Full Text] [Related]  

  • 4. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
    Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
    Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell epigenomic variability reveals functional cancer heterogeneity.
    Litzenburger UM; Buenrostro JD; Wu B; Shen Y; Sheffield NC; Kathiria A; Greenleaf WJ; Chang HY
    Genome Biol; 2017 Jan; 18(1):15. PubMed ID: 28118844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation.
    Ohsawa S; Takemoto D; Igaki T
    J Biochem; 2014 Sep; 156(3):129-36. PubMed ID: 25012819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
    Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
    J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour heterogeneity.
    Marte B
    Nature; 2013 Sep; 501(7467):327. PubMed ID: 24048064
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 12. Current projects in Pre-analytics: where to go?
    Sapino A; Annaratone L; Marchiò C
    Recent Results Cancer Res; 2015; 199():65-70. PubMed ID: 25636430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous influx of newly transformed cells as a source of tumor clonal heterogeneity].
    Likhtenshteĭn AV
    Vopr Onkol; 2007; 53(5):596-7. PubMed ID: 18154128
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
    Prick J; de Haan G; Green AR; Kent DG
    Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specimen collection and handling.
    Suryaatmadja M
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():158-65. PubMed ID: 10926276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular entities of the breast cancer: the difference is in the origin].
    Charafe-Jauffret E; Ginestier C
    Ann Pathol; 2012 Nov; 32(5 Suppl):S35-6. PubMed ID: 23127933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.